Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-16 4:21 pm Sale | 2026-09-30 | 13G | STOKE THERAPEUTICS INC STOK | Baker Bros. Advisors LP | 3,165,864 4.700% | -170,833![]() (-5.12%) | Filing History |
| 2026-11-16 12:01 pm Purchase | 2026-09-30 | 13G | STOKE THERAPEUTICS INC STOK | Wellington Management Group LLP | 4,681,855 7.300% | 1,586,155![]() (+51.24%) | Filing History |
| 2026-11-16 08:38 am Purchase | 2026-09-30 | 13G | STOKE THERAPEUTICS INC STOK | RTW Investments, LP | 6,537,475 9.900% | 596,609![]() (+10.04%) | Filing History |
| 2026-11-13 4:38 pm Sale | 2026-09-30 | 13G | STOKE THERAPEUTICS INC STOK | Morgan Stanley MS | 3,177,169 4.900% | -249,570![]() (-7.28%) | Filing History |
| 2026-11-05 1:27 pm Sale | 2026-09-30 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 4,820,462 7.500% | -492,638![]() (-9.27%) | Filing History |
| 2026-09-30 6:30 pm Purchase | 2026-09-23 | 13G | STOKE THERAPEUTICS INC STOK | BIOTECHNOLOGY VALUE FUND L P | 3,608,968 5.600% | 3,608,968![]() (New Position) | Filing History |
| 2026-08-14 4:33 pm Sale | 2026-06-30 | 13G | STOKE THERAPEUTICS INC STOK | Lynx1 Capital Management LP | 4,038,404 6.500% | -725,269![]() (-15.22%) | Filing History |
| 2026-08-12 4:10 pm Unchanged | 2026-06-30 | 13G | STOKE THERAPEUTICS INC STOK | TORONTO DOMINION BANK | 3,173,258 4.900% | 0 (Unchanged) | Filing History |
| 2026-08-06 10:41 am Sale | 2026-06-30 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 5,313,100 8.500% | -287,820![]() (-5.14%) | Filing History |
| 2026-05-18 9:30 pm Purchase | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | Lynx1 Capital Management LP | 4,763,673 8.100% | 642,429![]() (+15.59%) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | Lynx1 Capital Management LP | 4,121,244 7.000% | -1,065,947![]() (-20.55%) | Filing History |
| 2026-05-15 4:16 pm Sale | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | Redmile Group, LLC | 4,164,120 6.700% | -211,811![]() (-4.84%) | Filing History |
| 2026-05-15 1:46 pm Unchanged | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | TORONTO DOMINION BANK | 3,173,258 5.400% | 0 (Unchanged) | Filing History |
| 2026-05-15 08:32 am Purchase | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | RTW Investments, LP | 5,940,866 9.900% | 630,833![]() (+11.88%) | Filing History |
| 2026-05-15 07:06 am Purchase | 2026-03-31 | 13G | STOKE THERAPEUTICS INC STOK | Wellington Management Group LLP | 3,095,700 5.200% | 3,095,700![]() (New Position) | Filing History |
| 2026-03-27 1:18 pm Sale | 2026-03-13 | 13G | STOKE THERAPEUTICS INC STOK | VANGUARD GROUP INC | 0 0.000% | -2,759,247![]() (Position Closed) | Filing History |
| 2026-02-17 4:13 pm Sale | 2025-12-31 | 13G | STOKE THERAPEUTICS INC STOK | Baker Bros. Advisors LP | 3,336,697 5.800% | -1,031,746![]() (-23.62%) | Filing History |
| 2026-02-05 1:36 pm Sale | 2025-12-31 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 5,600,920 9.800% | -1,264,137![]() (-18.41%) | Filing History |
| 2025-11-14 11:27 am Sale | 2025-09-30 | 13G | STOKE THERAPEUTICS INC STOK | Cowen Financial Products LLC | 0 0.000% | -3,173,258![]() (Position Closed) | Filing History |
| 2025-11-14 11:24 am Purchase | 2025-09-30 | 13G | STOKE THERAPEUTICS INC STOK | TORONTO DOMINION BANK | 3,173,258 5.800% | 3,173,258![]() (New Position) | Filing History |

